Jorveza is indicated for the treatment of eosinophilic esophagitis (EoE) in adults.
Eosinophilic esophagitis is an inflammation of the esophagus that causes dysphagia (difficulty swallowing) and blockage of the esophagus. This is caused by a large accumulation of eosinophil leukocytes in the esophageal mucosa.
Active ingredient: budesonide
Prescription medicine.